<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> is a common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> of the lymphoid system </plain></SENT>
<SENT sid="1" pm="."><plain>Although the scarce Hodgkin and Reed-Sternberg (HRS) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells in involved tissue synthesize major histocompatibility complex (MHC) class II and costimulatory molecules such as CD40 or CD86, it is unclear whether these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells are operational antigen-presenting cells (APC) </plain></SENT>
<SENT sid="2" pm="."><plain>We developed an immunofluorescence-based assay to determine the number of MHC class II molecules present on the surface of single living HRS cells </plain></SENT>
<SENT sid="3" pm="."><plain>We found that in fresh <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> lymph node biopsies, a subset of HRS cells express a substantial number of surface MHC class II molecules that are occupied by MHC class II-associated invariant chain <z:chebi fb="7" ids="16670">peptides</z:chebi> (CLIP), indicating deficient loading of MHC class II molecules with antigenic <z:chebi fb="7" ids="16670">peptides</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Cultured <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>-derived (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) cell lines, however, were found to express few MHC class II molecules carrying CLIP <z:chebi fb="7" ids="16670">peptides</z:chebi> on the cell surface and were shown to generate <z:chebi fb="0" ids="8984">sodium dodecyl sulphate</z:chebi> (<z:chebi fb="26" ids="8984">SDS</z:chebi>)-stable MHC class II alphabeta dimers </plain></SENT>
<SENT sid="5" pm="."><plain>In addition to showing deficient MHC class II antigen presentation in a subset of HRS cells, our results show that the widely used <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-cell lines are not ideal in vitro models for the disease </plain></SENT>
<SENT sid="6" pm="."><plain>The disruption of MHC class II-restricted antigen presentation in HRS cells could represent a key mechanism by which these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells escape immune surveillance </plain></SENT>
</text></document>